Changes in the serum composition of free-fatty acids during an intravenous glucose tolerance test

Obesity

Volumn 17, Issue 1, 2009, Pages 10-15

  Soriguer, Federico ^a,b   García Serrano, Sara ^b   García Almeida, Jose M ^c   Garrido Sánchez, Lourdes ^d   García Arnés, Juan ^a   Tinahones, Francisco J ^c,d   Cardona, Isabel ^e   Rivas Marín, Jose ^c   Gallego Perales, Jose L ^a   García Fuentes, Eduardo ^a,d,e  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^d Instituto de Salud Carlos III   (Spain)

^e Hospital University Carlos Haya de Málaga   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; INSULIN;

ADULT; ARTICLE; BARIATRIC SURGERY; BLOOD; BODY MASS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; MALE; METABOLISM; MIDDLE AGED; MORBID OBESITY; WEIGHT REDUCTION;

ADULT; BARIATRIC SURGERY; BLOOD GLUCOSE; BODY MASS INDEX; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; MIDDLE AGED; OBESITY, MORBID; WEIGHT LOSS;

EID: 57949095094     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.475     Document Type: Article

References (31)

1. Olshansky SJ, Passaro DJ, Hershow RC et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 2005;352:1138-1145.
2. Boden G. Free fatty acids-the link between obesity and insulin resistance. Endocr Pract 2001;7:44-51.
3. Hirabara SM, Silveira LR, Alberici LC et al. Acute effect of fatty acids on metabolism and mitochondrial coupling in skeletal muscle. Biochim Biophys Acta 2006;1757:57-66.
4. Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 1998;14:263-283.
5. Charles MA, Eschwege E, Thibult N et al. The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study. Diabetologia 1997;40:1101-1106.
6. Knowler WC, Pettitt DJ, Saad MF, Bennett PH. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev 1990;6:1-27.
7. Rojo-Martinez G, Esteva I, Ruiz de Adana MS et al. Dietary fatty acids and insulin secretion: a population-based study. Eur J Clin Nutr 2006;60:1195-1200.
8. Rickels MR, Naji A, Teff KL. Insulin sensitivity, glucose effectiveness, and free fatty acid dynamics after human islet transplantation for type 1 diabetes. J Clin Endocrinol Metab 2006;91:2138-2144.
9. Sumner AE, Bergman RN, Vega GL et al. The multiphasic profile of free fatty acids during the intravenous glucose tolerance test is unresponsive to exogenous insulin. Metabolism 2004;53:1202-1207.
10. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 2002;56:365-379.
11. Pacini G, Bergman RN. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Meth Prog Bio 1986;23:113-122.
12. Garcia-Fuentes E, Garcia-Almeida JM, Garcia-Arnes J et al. Morbidly obese persons with impaired fasting glucose have a specific pattern of insulin secretion and sensitivity. Effect of weight loss after bariatric surgery. Obes Surg 2006;16;1179-1188.
13. Folch J, Less M, Sloane-Stanley GM. A Simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 1957;226:497-509.
14. Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 1986;27:114-120.
15. Bergman RN. Toward physiological understanding of glucose tolerance: minimal-model approach (Lilly Lecture). Diabetes 1989;38:1512-1527.
16. Godsland IF, Jeffs JA, Johnston DG. Loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia 2004;47: 1157-1166.
17. McLachlan KA, Boston R, Alford FP. Impaired non-esterified fatty acid suppression to intravenous glucose during late pregnancy persists postpartum in gestational diabetes: a dominant role for decreased insulin secretion rather than insulin resistance. Diabetologia 2005;48: 1373-1379.
18. Kleimbaun DG, Kupper LL, Keith EM. Applied Regression Analysis and Other Multivariable Methods. PWS-Kent Publishing Company:Boston, 1988.
19. Prando R, Cordera R, De Micheli A et al. I.V. glucose tolerance test: correlation between FFA, glucose and IRI in normal, obese and diabetic subjects. Acta Diabetol Lat 1978;15:259-272.
20. Jansson PA, Fowelin JP, von Schenck HP, Smith UP, Lönnroth PN. Measurement by microdialysis of the insulin concentration in subcutaneous interstitial fluid. Importance of the endothelial barrier for insulin. Diabetes 1993;42:1469-1473.
21. Lindegaard B, Frøsig C, Petersen AM et al. Inhibition of lipolysis stimulates peripheral glucose uptake but has no effect on endogenous glucose production in HIV lipodystrophy. Diabetes 2007;56:2070-2077.
22. Bonadonna RC, Groop LC, Zych K, Shank M, DeFronzo RA. Dosedependent effect of insulin on plasma free fatty acid turnover and oxidation in humans. Am J Physiol 1990;259:E736-E750.
23. Abdul-Ghani MA, Molina-Carrion M, Jani R, Jenkinson C, Defronzo RA. Adipocytes in subjects with impaired fasting glucose and impaired glucose tolerance are resistant to the anti-lipolytic effect of insulin. Acta Diabetol 2008;45:147-150.
24. Zoratti R, Godsland IF, Chaturvedi N et al. Relation of plasma lipids to insulin resistance, nonesterified fatty acid levels, and body fat in men from three ethnic groups: relevance to variation in risk of diabetes and coronary disease. Metabolism 2000;49:245-252.
25. Kelley DE, Kuller LH, McKolanis TM et al. Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes. Diabetes Care 2004;27:33-40.
26. Gumbs AA, Modlin IM, Ballantyne GH. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg 2005;15:462-473.
27. Wickremesekera K, Miller G, Naotunne TD, Knowles G, Stubbs RS. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes Surg 2005;15:474-481.
28. García-Fuentes E, García-Almeida JM, García- Arnés J et al. Plasma visfatin concentrations in severely obese subjects are increased after intestinal bypass. Obesity (Silver Spring) 2007;15:2391-2395.
29. Harber MP, Schenk S, Barkan AL, Horowitz JF. Alterations in carbohydrate metabolism in response to short-term dietary carbohydrate restriction. Am J Physiol Endocrinol Metab 2005;289:E306-E312.
30. Raclot T. Selective mobilization of fatty acids from adipose tissue triacylglycerols. Prog Lipid Res 2003;42:257-288.
31. Mittendorfer B, Liem O, Patterson BW, Miles JM, Klein S. What does the measurement of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean? Diabetes 2003;52:1641-1648.